Hedge Fund - OrbiMed Advisors
Celgene Corp (CELG)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2019 - Q2 (2019-06-30) | $0 | 0% | 0 | $94.96 |
| 2 | 2019 - Q1 (2019-03-31) | $27,830,000 | 0.43% | 295,000 | $87.46 |
| 3 | 2018 - Q4 (2018-12-31) | $208,722,000 | 3.85% | 3,256,700 | $73.82 |
| 4 | 2018 - Q3 (2018-09-30) | $220,490,000 | 2.65% | 2,463,850 | $88.37 |
| 5 | 2018 - Q2 (2018-06-30) | $204,161,000 | 2.43% | 2,570,650 | $83.03 |
| 6 | 2018 - Q1 (2018-03-31) | $235,001,000 | 2.91% | 2,634,250 | $96.00 |
| 7 | 2017 - Q4 (2017-12-31) | $319,639,000 | 4.04% | 3,062,850 | $112.84 |
| 8 | 2017 - Q3 (2017-09-30) | $488,785,000 | 4.67% | 3,351,977 | $136.21 |
| 9 | 2017 - Q2 (2017-06-30) | $444,906,000 | 4.66% | 3,425,777 | $122.53 |
| 10 | 2017 - Q1 (2017-03-31) | $389,737,000 | 4.41% | 3,132,177 | $119.67 |
| 11 | 2016 - Q4 (2016-12-31) | $359,609,000 | 4.58% | 3,106,777 | $111.36 |
| 12 | 2016 - Q3 (2016-09-30) | $308,215,000 | 3.51% | 2,948,577 | $108.23 |
| 13 | 2016 - Q2 (2016-06-30) | $237,173,000 | 2.47% | 2,404,677 | $103.44 |
| 14 | 2016 - Q1 (2016-03-31) | $377,747,000 | 3.97% | 3,774,077 | $102.97 |
| 15 | 2015 - Q4 (2015-12-31) | $438,974,000 | 3.97% | 3,665,450 | $115.69 |
| 16 | 2015 - Q3 (2015-09-30) | $388,655,000 | 3.92% | 3,593,000 | $124.10 |
| 17 | 2015 - Q2 (2015-06-30) | $442,802,000 | 3.7% | 3,826,000 | $114.32 |
| 18 | 2015 - Q1 (2015-03-31) | $365,668,000 | 3.12% | 3,172,000 | $119.49 |
| 19 | 2014 - Q4 (2014-12-31) | $409,139,000 | 3.9% | 3,657,600 | $105.46 |
| 20 | 2014 - Q3 (2014-09-30) | $315,428,000 | 3.29% | 3,328,000 | $90.24 |
| 21 | 2014 - Q2 (2014-06-30) | $228,011,000 | 2.67% | 2,655,000 | $76.05 |
| 22 | 2014 - Q1 (2014-03-31) | $191,447,000 | 2.35% | 1,371,400 | $79.19 |
| 23 | 2013 - Q4 (2013-12-31) | $296,894,000 | 4.36% | 1,757,100 | $79.12 |
| 24 | 2013 - Q3 (2013-09-30) | $201,457,000 | 3.59% | 1,307,000 | $70.08 |
| 25 | 2013 - Q2 (2013-06-30) | $144,634,000 | 3.06% | 1,236,400 | $60.17 |
| 26 | 2013 - Q1 (2013-03-31) | $144,308,000 | 3.35% | 1,245,000 | $50.98 |
| 27 | 2012 - Q4 (2012-12-31) | $64,691,000 | 1.99% | 824,400 | $38.70 |
| 28 | 2012 - Q3 (2012-09-30) | $28,574,000 | 0.82% | 374,000 | $35.33 |
| 29 | 2012 - Q1 (2012-03-31) | $41,628,000 | 1.23% | 537,000 | $36.87 |
| 30 | 2011 - Q4 (2011-12-31) | $56,378,000 | 1.84% | 834,000 | $32.17 |
| 31 | 2011 - Q3 (2011-09-30) | $16,035,000 | 0.59% | 259,000 | $29.64 |
| 32 | 2011 - Q2 (2011-06-30) | $21,619,000 | 0.4% | 358,400 | $29.34 |
| 33 | 2011 - Q1 (2011-03-31) | $28,237,000 | 0.95% | 490,400 | $27.21 |
| 34 | 2010 - Q4 (2010-12-31) | $54,894,000 | 1.97% | 928,200 | $29.72 |
The displayed share prices are average quarterly stock market prices.